(Q57950971)

7

0 references

Angelo Corti

object named as

Angelo Corti

10

0 references

author name string

Vanesa Gregorc

1

0 references

Anna Spreafico

2

0 references

Irene Floriani

3

0 references

Vienna Ludovini

5

0 references

Lorenza Pistola

6

0 references

Maria Grazia Viganò

8

0 references

Eugenio Villa

The granin protein family: markers for neuroendocrine cells and tools for the diagnosis of neuroendocrine tumors

9

0 references

language of work or name

English

0 references

publication date

2007

0 references

published in

Cancer

0 references

volume

110

0 references

issue

4

0 references

page(s)

845-853

0 references

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22856

Plasma chromogranin A marks emesis and serotonin release associated with dacarbazine and nitrogen mustard but not with cyclophosphamide-based chemotherapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22856

The chromogranins A and B: the first 25 years and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22856

7 January 2021

The chromogranin-secretogranin family

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22856

7 January 2021

Radioimmunoassay of chromogranin A in plasma as a measure of exocytotic sympathoadrenal activity in normal subjects and patients with pheochromocytoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22856

7 January 2021

Hormone-negative, chromogranin A-positive endocrine tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22856

7 January 2021

Chromogranin A: its role in endocrine function and as an endocrine and neuroendocrine tumor marker

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22856

7 January 2021

Neuroendocrine differentiation in carcinoma of the breast. Tyramide signal amplification discloses chromogranin A-positive tumour cells in more breast tumours than previously realized

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22856

7 January 2021

Chromogranins in non-endocrine tumours

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22856

7 January 2021

Chromogranin A and chromogranin B in noninvasive and invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22856

7 January 2021

Clinical characterization of pulmonary large cell neuroendocrine carcinoma and large cell carcinoma with neuroendocrine morphology

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22856

7 January 2021

Norepinephrine clearance, chromogranin A and dopamine beta hydroxylase in renal failure.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22856

7 January 2021

Clinical significance of elevated serum chromogranin A levels

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22856

7 January 2021

Basal chromogranin A and gastrin concentrations in circulation correlate to endocrine cell proliferation in type-A gastritis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22856

7 January 2021

Effect of short-term treatment with low dosages of the proton-pump inhibitor omeprazole on serum chromogranin A levels in man.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22856

7 January 2021

Chromogranin A and tumor necrosis factor-alpha (TNF) in chronic heart failure

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22856

7 January 2021

Chromogranin A in heart failure; a novel neurohumoral factor and a predictor for mortality.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22856

7 January 2021

Plasma chromogranin A: a marker of serotonin release and of emesis associated with cisplatin chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22856

7 January 2021

Revisions in the International System for Staging Lung Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22856

7 January 2021

Antigenic Regions of Human Chromogranin A and their Topographic Relationships with Structural/Functional Domains

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22856

7 January 2021

Elevated serum chromogranin A concentrations in small-cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22856

7 January 2021

The prognostic significance of circulating neuroendocrine markers chromogranin a, pro-gastrin-releasing peptide and neuron-specific enolase in patients with advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22856

7 January 2021

Chromogranin A in Tumors: More Than a Marker for Diagnosis and Prognosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22856

7 January 2021

Neuroendocrine differentiation in carcinomas of the prostate: do neuroendocrine serum markers reflect immunohistochemical findings?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22856

7 January 2021

Neuroendocrine differentiation is an independent prognostic factor in chemotherapy-treated nonsmall cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22856

7 January 2021

Use of neuroendocrine markers, p53, and HER2 to predict response to chemotherapy in patients with stage III non-small cell lung cancer: a Cancer and Leukemia Group B study.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22856

7 January 2021

Neuroendocrine differentiation as a prognostic factor in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22856

7 January 2021

The predictive value of neuroendocrine markers and p53 for response to chemotherapy and survival in patients with advanced non-small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22856

7 January 2021

Tumor necrosis factor-alpha in the pathogenesis and treatment of cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22856

7 January 2021

Tumour necrosis factor alpha: a potential target for the therapy of solid tumours.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22856

7 January 2021

The potential biological and clinical significance of the soluble tumor necrosis factor receptors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22856

7 January 2021